(NASDAQ: MDLN) Medline's forecast annual revenue growth rate of 7.32% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.61%.
Medline's revenue in 2026 is $29,939,000,000.On average, 29 Wall Street analysts forecast MDLN's revenue for 2026 to be $41,874,748,327,692, with the lowest MDLN revenue forecast at $39,978,940,124,228, and the highest MDLN revenue forecast at $43,458,970,855,552. On average, 29 Wall Street analysts forecast MDLN's revenue for 2027 to be $45,168,090,595,152, with the lowest MDLN revenue forecast at $43,006,711,478,304, and the highest MDLN revenue forecast at $47,095,451,778,424.
In 2028, MDLN is forecast to generate $48,695,450,796,188 in revenue, with the lowest revenue forecast at $46,125,197,649,328 and the highest revenue forecast at $51,599,639,646,016.